Oxidant-free cross-dehydrogenative oxyalkylation enables late-stage functionalization of drugs
Zhibo Liu(First Affiliated Hospital of Zhengzhou University), Chao‐Jun Li(Centre in Green Chemistry and Catalysis), Bo‐Shuai Mu(Peking University), Mengxin Xu(Peking University), Xi‐Yang Cui(Chinese Academy of Medical Sciences & Peking Union Medical College), Yang Xu(Lawrence Livermore National Laboratory), Longlong Song(Peking University), Jiahao Li(Peking University), Jianbin Li(Peking University), Zhiyu Tu(Peking University), Chung-Cheng Wu(Peking University)
Cited by 0
Related Papers
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
CuBr-Catalyzed Efficient Alkynylation of sp<sup>3</sup> C−H Bonds Adjacent to a Nitrogen Atom
|Journal of the American Chemical Society|2004|665
Reactions of C−H Bonds in Water
|Chemical Reviews|2007|631
Cu-catalyzed cross-dehydrogenative coupling: A versatile strategy for C–C bond formations via the oxidative activation of sp <sup>3</sup> C–H bonds
|Proceedings of the National Academy of Sciences|2006|592
Highly Efficient Copper-Catalyzed Nitro-Mannich Type Reaction: Cross-Dehydrogenative-Coupling between sp<sup>3</sup> C−H Bond and sp<sup>3</sup> C−H Bond
|Journal of the American Chemical Society|2005|538